However, their pitch quickly took an unexpected turn when they faced intense scrutiny, with accusations of “manipulating sales figures” and Vineeta Singh remarking, “Daal mein kuch kaala hai.” ...

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse ...

MOSCOW, Feb 14 (Reuters) - Authorities in Russia have detained a U.S. citizen at a Moscow airport on drug smuggling charges, Mash, a Telegram channel which has sources in Russia's security ...

Yes, metabolic dysfunction-associated steatohepatitis (MASH) can result in cirrhosis of the liver. Formerly known as nonalcoholic steatohepatitis (NASH), MASH describes a type of metabolic ...

What was seemingly a regular post-voting picture suddenly turned interesting with a cheeky comment popping up: "Agle 50 saal ka vote ek hi baar me daal ke aa gye kya? " Social media users couldn't ...

Fortnite's February 2025 Crew Pack features Haruka of the Masks outfit,new back bling, and pickaxe. Fans excited for Japanese-themed skin. January's Crew Pack had mixed reviews, but February's ...

Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic dysfunction-associated steatohepatitis (MASH) analyses to send its stock up about 100%.

At 10.30am on a chilly Saturday the queue outside Manze’s pie-and-mash shop on Deptford High Street stretches 50 metres down the street. The restaurant has been a fixture of the south-east ...

Alcohol-free beer brand Mash Gang captured the interest of Brighton locals after setting up a graveyard and took over a Brighton beach bar. Team members of the brewer handed out cans of its beer then ...

The first DLC pack for the fighting game has been revealed, and it's adding 11 new fighters to the mix. The Heroes of Justice Pack will be available to all season pass owners after it's released ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...